ZBTB40 and inflammatory bowel disease: Clinical evidence suggests that IBD patients carrying certain ZBTB40 variants exhibit an increased risk of fractures [50], which may be attributed to the factor’s dual regulatory influence on both bone metabolism and inflammatory processes.